Abbott Laboratories (ABT) is 1.29% away from 50-day simple Moving Average despite all headwinds

On Friday, Abbott Laboratories (NYSE: ABT) opened lower -0.68% from the last session, before settling in for the closing price of $105.96. Price fluctuations for ABT have ranged from $89.67 to $121.64 over the past 52 weeks.

Annual sales at Healthcare sector company grew by 6.10% over the past five years. Company’s average yearly earnings per share was noted 4.96% at the time writing. With a float of $1.73 billion, this company’s outstanding shares have now reached $1.73 billion.

Let’s look at the performance matrix of the company that is accounted for 114000 employees.

Abbott Laboratories (ABT) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Abbott Laboratories is 0.72%, while institutional ownership is 79.13%. The most recent insider transaction that took place on May 10 ’24, was worth 1,055,819. In this transaction EXECUTIVE VICE PRESIDENT of this company sold 10,097 shares at a rate of $104.57, taking the stock ownership to the 211,341 shares. Before that another transaction happened on May 07 ’24, when Company’s EXECUTIVE VICE PRESIDENT sold 22,852 for $106.25, making the entire transaction worth $2,428,119. This insider now owns 61,462 shares in total.

Abbott Laboratories (ABT) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 4.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.15% during the next five years compared to 19.65% growth over the previous five years of trading.

Abbott Laboratories (NYSE: ABT) Trading Performance Indicators

Check out the current performance indicators for Abbott Laboratories (ABT). In the past quarter, the stock posted a quick ratio of 1.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.50. Likewise, its price to free cash flow for the trailing twelve months is 37.19.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.17, a number that is poised to hit 1.20 in the next quarter and is forecasted to reach 5.14 in one year’s time.

Technical Analysis of Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) saw its 5-day average volume 7.48 million, a positive change from its year-to-date volume of 5.87 million. As of the previous 9 days, the stock’s Stochastic %D was 76.74%. Additionally, its Average True Range was 2.13.

During the past 100 days, Abbott Laboratories’s (ABT) raw stochastic average was set at 25.22%, which indicates a significant decrease from 61.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.90% in the past 14 days, which was higher than the 19.53% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $103.92, while its 200-day Moving Average is $106.78. Nevertheless, the first resistance level for the watch stands at $106.70 in the near term. At $108.16, the stock is likely to face the second major resistance level. The third major resistance level sits at $109.18. If the price goes on to break the first support level at $104.22, it is likely to go to the next support level at $103.20. The third support level lies at $101.74 if the price breaches the second support level.

Abbott Laboratories (NYSE: ABT) Key Stats

There are currently 1,739,634K shares outstanding in the company with a market cap of 183.08 billion. Presently, the company’s annual sales total 40,109 M according to its annual income of 5,723 M. Last quarter, the company’s sales amounted to 10,377 M and its income totaled 1,302 M.